Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.23.4
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Oct. 31, 2023
Oct. 31, 2022
Income Statement [Abstract]    
Revenue $ 210
Operating costs and expenses:    
Inventor royalties, contingent legal fees, litigation and licensing expenses 161
Research and development expenses (including non-cash share based compensation expenses of $2,037 and $3,635, respectively) 4,769 6,703
General and administrative expenses (including non-cash share based compensation expenses of $2,698 and $3,117, respectively) 6,291 7,172
Total operating costs and expenses 11,221 13,875
Loss from operations (11,011) (13,875)
Interest income 1,081 104
Net loss (9,930) (13,771)
Less: Net loss attributable to noncontrolling interest (119) (176)
Net loss attributable to common stockholders $ (9,811) $ (13,595)
Net loss per share:    
Basic $ 0.32 $ 0.45
Diluted $ 0.32 $ 0.45
Weighted average common shares outstanding:    
Basic 30,980 30,374
Diluted 30,980 30,374